阜阳毛囊炎看的较好的医院-【阜阳皮肤病医院】,阜阳皮肤病医院,阜阳市治疗皮肤病好点的医院,阜阳有什么看皮肤科的医院吗,阜阳皮肤科医院的在那,阜阳怎样治疗湿诊更好,阜阳哪些医院荨麻疹好一些,阜阳市那个痤疮医院比较好
阜阳毛囊炎看的较好的医院阜阳皮肤癣好治吗,阜阳那家医院治疗荨麻疹治的好,皮肤科在阜阳哪个医院比较好,阜阳市哪里治荨麻疹好,阜阳那个医院皮肤科治的好,激光祛痘祛阜阳哪家医院比较好,阜阳重度痤疮医院
The check-in experience of the future just landed at @fly2ohare! Using industry-leading technology, we’re limiting face-to-face interaction and streamlining the check-in process for our Guests. Now that’s #MoreGo! pic.twitter.com/e6i3v7aa6s— Spirit Airlines (@SpiritAirlines) September 3, 2020 301
The Centers for Disease Control and Prevention said on Thursday that it’s investigating salmonella cases linked to pet bearded dragons and hedgehogs.The CDC said that 13 salmonella infections in eight states have been potentially tied to handling the pets. The CDC confirmed that seven of the infections resulted in hospitalizations. Ten of the 13 ill people reported contact with a bearded dragon.Those who reported illnesses said they purchased bearded dragons from pet stores, but a common supplier has not been identified.The CDC said that two similar outbreaks were tied to hedgehogs in the last decade.The CDC offers owners of pet bearded dragons and hedgehogs the following tips:Always wash hands thoroughly with soap and water right after touching your pet or anything in its environment.Don’t kiss or snuggle your pet because this can spread Salmonella germs to your face and mouth and make youKeep your pet out of your kitchen and other areas where you eat, store, or prepare food.Clean items you use to care for your pet outside the house, if possible. If you clean the items indoors, clean them in a laundry sink or bathtub. Make sure to thoroughly disinfect the area right after.Don’t let children younger than 5 touch the bearded dragon or hedgehog because young children are more likely to have severe Salmonella illness.Before bringing home a new pet, research the pet’s needs and see if it’s a good fit for your family. 1444
The first cruise in the Caribbean since the start of the pandemic is reporting a COVID-19 case.A passenger aboard SeaDream Yacht Club’s SeaDream 1 received a preliminary positive COVID-19 test.According to passengers, the captain informed them about the preliminary positive test over the ship’s intercom system while they were anchored off the coast of Grenadines.The vessel is now headed back to Barbados, where it is based.The SeaDream is carrying 53 passengers and 66 crew, with the majority of passengers hailing from the U.S. according to Sue Bryant, who is aboard the ship and is a cruise editor for The Times and The Sunday Times in Britain.The SeaDream is the first vessel to resume sailing in the Caribbean since earlier this year when coronavirus pandemic concerns docked the cruise industry following high profile infections.Passengers were tested both in advance of traveling, before boarding, and again a few days into the trip.The SeaDream has a capacity of about 110 guests and 95 crewmembers. It also sails outside of U.S. waters. This puts it below the 250 guests threshold and outside the area under the CDC’s orders about cruising. 1159
The former football coach for The Ohio State University, Earle Bruce, died early Friday morning, ESPN reports.Bruce was the coach for the Buckeyes from 1979 to 1987 and had the difficult task of replacing legendary Buckeyes coach Woody Hayes. He was well-regarded, leading the team to four Big Ten titles and had a 5-3 record in bowl games. A number of his players, such as Jim Lachey, Keith Byars and Pepper Johnson, went onto pro careers. 478
The first experimental COVID-19 vaccine in the U.S. is on track to begin a huge study next month to prove if it really can fend off the coronavirus, while hard-hit Brazil is testing a different shot from China.Where to do crucial, late-stage testing and how many volunteers are needed to roll up their sleeves are big worries for health officials as the virus spread starts tapering off in parts of the world.Moderna Inc. said Thursday the vaccine it is developing with the National Institutes of Health will be tested in 30,000 people in the U.S. Some will get the real shot and some a dummy shot, as scientists carefully compare which group winds up with the most infections.With far fewer COVID-19 cases in China, Sinovac Biotech turned to Brazil, the epicenter of Latin America’s outbreak, for at least part of its final testing. The government of S?o Paulo announced Thursday that Sinovac will ship enough of its experimental vaccine to test in 9,000 Brazilians starting next month.If it works, “with this vaccine we will be able to immunize millions of Brazilians,” said S?o Paulo′s Gov. Joao Doria.Worldwide, about a dozen COVID-19 potential vaccines are in early stages of testing. The NIH expects to help several additional shots move into those final, large-scale studies this summer, including one made by Oxford University that’s also being tested in a few thousand volunteers in Brazil.There’s no guarantee any of the experimental shots will pan out.But if all goes well, “there will be potential to get answers” on which vaccines work by the end of the year, Dr. John Mascola, who directs NIH’s vaccine research center, told a meeting of the National Academy of Medicine on Wednesday.Vaccines train the body to recognize a virus and fight back, and specialists say it’s vital to test shots made in different ways — to increase the odds that at least one kind will work.Sinovac’s vaccine is made by growing the coronavirus in a lab and then killing it. So-called “whole inactivated” vaccines are tried-and-true, used for decades to make shots against polio, flu and other diseases — giving the body a sneak peek at the germ itself — but growing the virus is difficult and requires lab precautions.The vaccine made by the NIH and Moderna contains no actual virus. Those shots contain the genetic code for the aptly named “spike” protein that coats the surface of the coronavirus. The body’s cells use that code to make some harmless spike protein that the immune system reacts to, ready if it later encounters the real thing. The so-called mRNA vaccine is easier to make, but it’s a new and unproven technology.Neither company has yet published results of how their shots fared in smaller, earlier-stage studies, designed to check for serious side effects and how well people’s immune systems respond to different doses.Even before proof that any potential vaccine will work, companies and governments are beginning to stockpile millions of doses so they can be ready to start vaccinating as soon as answers arrive.In the U.S., a program called “Operation Warp Speed” aims to have 300 million doses on hand by January. Under Brazil’s agreement with Sinovac, the Instituto Butantan will learn to produce the Chinese shot.___AP journalist Marcelo Silva de Sousa contributed to this report.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 3499